Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.

Date publication

septembre 2025

Journal

ERJ open research

Auteurs

Membres identifiés du Cancéropôle Est :
Pr QUANTIN Catherine , Pr BONNIAUD Philippe , Dr BELTRAMO Guillaume

Tous les auteurs :
Tankéré P, Lajeune E, Mariet AS, Cottenet J, Beltramo G, Georges M, Bonniaud P, Favrolt N, Quantin C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40959166

Résumé

Although long-term effects of coronavirus disease-2019 (COVID-19) such as dyspnoea are frequent, the mechanisms are often poorly understood. The endothelial effects of COVID-19, such as venous or arterial thrombosis, are also well documented. Thus, the incidence of chronic thromboembolic pulmonary hypertension (CTEPH) following COVID-19 is an issue with many implications, particularly for screening in patients with long COVID.

Référence

ERJ Open Res. 2025 09;11(5):